On Sept. 17, 2024, in landmark research, scientists at The University of Texas Health Science Center at San…
On Aug. 22, 2024, the Medicines and Healthcare Products Regulatory Agency (MHRA) announced it had licensed the immunotherapy…
On Jul. 30, 2024, a head-to-head comparison of six commercially available blood tests for Alzheimer’s disease led by…
In Jul. 10, 2024, Eisai and Biogen announced that the Department of Health in Hong Kong has approved…
On Jun. 27, 2024, C2N Diagnostics (C2N), has entered into a non-exclusive agreement with Mayo Clinic Laboratories, for…
On Apr. 26, 2024, engineers at Washington University in St. Louis announced a new imaging technique that give…
On Feb. 24, 2024, C2N Diagnostics (C2N) announced the medical device registration from the United Kingdom’s Medicines and…
On Jan. 9, 2024, Biogen and Eisai announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody ‘LEQEMBI’…
On Sept. 26, 2023, the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department…
On Jul. 6, 2023, Eisai and Biogen announced that the U.S. Food and Drug Administration (FDA) had approved the…
On May 11, 2023, the U.S. Food and Drug Administration (FDA) announced the supplemental approval of Otsuka Pharmaceutical…
On Jan. 31, 2023, a team of researchers led by the Innovation Center for Neurological Disorders and Department…
On Jan. 6, 2023, the U.S. Food and Drug Administration (FDA) approved Leqembi (lecanemab-irmb) via the Accelerated Approval…
On Jul. 28, 2022, the Allen Institute announced a newly released dataset of 1.2M cells from brain donors…
On Apr. 22, 2022, Stanford University announced it was awarded a $75 million gift from Nike co-founder Phil…
On Feb. 22, 2022, Washington University in St. Louis announced that a blood test developed at the University’s…
On Jul. 29, 2021, the National Institutes of Health announced it had launched a new online research tool…
On Jun. 23, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
On Jun. 7, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
On Mar. 25, 2021, McGill University researchers led by Bratislav Misic announced a direct link between gene expression…
On Mar. 2, 2021, the NIH announced it had launched the next version of the Accelerating Medicines Partnership…
On Oct. 12, 2020, the Washington University School of Medicine in St. Louis announced a $14.6 million grant…
On Sept. 14, 2020, the National Institutes of Health (NIH) announced that it had added funding for more…
On Jun. 25, 2020, the Allen Institute announced a new a new $40.5 million collaborative research center in…
On Apr. 17, 2020, the National Institutes of Health (NIH) announced nearly $290 million of new funding for…
On Apr. 6, 2020, the first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) study…
On Mar. 16, 2020, new insights into the architecture of the brain were revealed by scientists at the…
On Oct 1, 2019, the National Institute on Aging (NIA) announced it had awarded approximately $37 million over…
On Sept. 5, 2019, Penn Professor Virginia M.Y. Lee, PhD received the Breakthrough Prize in Life Sciences, in…
On Dec 3, 2018, a University of California, Los Angeles (UCLA) led research team announced they had identified…